Tumour Necrosis Factor  Gene Promoter and its Role in Rheumatoid Arthritis Outcome and Pharmacogenetics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|4|275-279

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.4, 2007-12, pp. : 275-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour necrosis factor blockade in rheumatoid arthritis

By Breedveld Ferdinand C  

Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. : 107-109

Royal College Of Physicians

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid Arthritis

By Camussi G.   Lupia E.  

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 613-620

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor- blockade: a new era for effective management of rheumatoid arthritis

By Hamilton K.   St. Clair E.W.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1041-1052

Informa Healthcare

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Antagonists in the Management of Rheumatoid Arthritis in the Elderly: A Review of Their Efficacy and Safety

By Radovits Beáta J.   Kievit Wietske   Laan Roland F.J.M.  

Drugs & Aging, Vol. 26, Iss. 8, 2009-08 ,pp. : 647-664

Adis International

Access to resources Recommend Favorite

The Case of Tumour Necrosis Factor-α Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis

By Sørensen Jan  

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 289-298

Adis International

Access to resources Recommend Favorite